Abstract
Cardiac disease is a major cause of maternal death. The number of such cardiac patients at risk is expected to grow. Women with pulmonary hypertension, severe left ventricular outflow stenosis, cyanotic congenital heart disease, aortic root dilatation, cardiac dysfunction, and mechanical valves have a high risk. The most frequent complications during pregnancy and delivery are heart failure and arrhythmias. Risk stratification for pregnancy and heart disease relates to the functional status of the patient and is lesion specific. Timely prepregnancy counseling should be offered to all women with heart disease in order to prevent avoidable pregnancy-related risks. Adequate care during pregnancy, delivery, and the postpartum period requires a multidisciplinary team approach with cardiologists, obstetricians, and anesthesiologists and other related disciplines. Successful pregnancy is feasible for most women with heart disease with a relatively low risk when appropriate counseling and optimal care are provided.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Niwa K, Aomi S, Akagi T, et al Diagnosis and treatment of cardiovascular diseases (2009 Joint Working Groups Report). Guidelines for indication and management of pregnancy and delivery in women with heart disease (JCS 2010, revised). http://www.j-circ.or.jp/guideline/pdf/JCS2010niwa.h.pdf
JCS Joint Working Group (2012) Guidelines for indication and management of pregnancy and delivery in women with heart disease (JCS 2010) digest version. Circ J 76:240–260
Gelson E, Ogueh O, Johnson M (2006) Cardiac changes in normal pregnancy. In: Steer PJ, Gatzoulis MA, Baker P (eds) Heart disease and pregnancy. RCOG Press, London, pp 29–44
Mabie WC, DiSessa TG, Crocker LG et al (1994) A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol 170:849–856
Poppas A, Shroff SG, Korcarz CE et al (1997) Serial assessment of the cardiovascular system in normal pregnancy. Circulation 95:2407–2415
Niwa K, Perloff JK, Bhuta SM et al (2001) Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation 103:393–400
Katsuragi S, Ueda K, Yamanaka K et al (2011) Pregnancy-associated aortic dilatation or dissection in Japanese women with Marfan syndrome. Circ J 75:2545–2551
Niwa K, Tateno S, Akagi T et al (2007) Arrhythmia and reduced heart rate variability during pregnancy in women with congenital heart disease and previous reparative surgery. Int J Cardiol 122:143–148
Ohuchi H, Tanabe Y, Kamiya C et al (2013) Cardiopulmonary variables during exercise predict pregnancy outcome in women with congenital heart disease. Circ J 77:470–476
Kamiya C, Nakatani S, Hashimoto S et al (2008) Role of echocardiography in assessing pregnant women with and without heart disease. J Echocardiogr 6:29–38
Colman JM, Silversides CK, Sermer M et al (2006) Cardiac monitoring during pregnancy. In: Steer PJ, Gatzoulis MA, Baker P (eds) Heart disease and pregnancy. RCOG Press, London, pp 67–77
DeWilde JP, Rivers AW, Price DL (2005) A review of the current use of magnetic resonance imaging in pregnancy and safety implications for fetus. Prog Biophys Mol Biol 87:335–353
Silka M, Hardy B, Menashe V et al (1998) A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 32:245–251
Gatzoulis MA, Balaji S, Webber SA et al (2000) Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicenter study. Lancet 356:975–981
Shotan A, Ostrzega E, Mehra A et al (1997) Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Caridiol 79:1061–1064
Joglar JA, Page RL (2001) Antiarrhythmic drugs in pregnancy. Curr Opin Cardiol 16:40–45
Brodsky M, Doria R, Allen B et al (1992) New-onset ventricular tachycardia during pregnancy. Am Heart J 123:933–941
Tateno S, Niwa K, Nakazawa M et al (2003) Arrhythmia and conduction disturbances in patients with congenital heart disease during pregnancy – multicenter study. Circ J 67:992–997
Dalvi BV, Chaudhuri A, Kulkarni HL et al (1992) Therapeutic guidelines for congenital heart block presenting in pregnancy. Obstet Gynecol 79:802–804
Egidy AG, Cassater D, Landzberg M et al (2013) The effects of pregnancy on right ventricular remodeling in women with repaired tetralogy of Fallot. Int J Cardiol 168:1847–1852
Kamiya CA, Iwamiya T, Neki R et al (2012) Outcome of pregnancy and effects on the right heart in women with repaired tetralogy of Fallot. Circ J 76:957–963
Siu SC, Sermer M, Harrison DA et al (1997) Risk and predictors for pregnancy-related complications in woman with heart disease. Circulation 96:2789–2794
Buttar HS (1997) An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development. Mol Cell Biochem 176:61–71
Cooper WO, Hernandez-Diaz S, Arbogast PG et al (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354:2443–2451
Presbitero P, Prever SB, Brusca A (1996) Interventional cardiology in pregnancy. Eur Heart J 17:182–188
Wloch A, Respondek-Liberska M, Sysa A et al (2004) Significant aortic and pulmonary valve stenosis in the prenatal period: diagnosis, treatment and outcome: a two-centre study. Acta Cardiol 59:242–243
Parry AJ, Westaby S (1996) Cardiopulmonary bypass during pregnancy. Ann Thorac Surg 61:1865–1869
Colman JM, Sermer M, Seaward PG et al (2000) Congenital heart disease in pregnancy. Cardiol Rev 8:166–173
Child J, Perloff JK, Koos B (2009) Management of pregnancy and contraception in congenital heart disease. In: Perloff JK, Child JS, Aboulhosn J (eds) Congenital heart disease in adults, 3rd edn. Saunders/Elsevier, Philadelphia, pp 194–220
Guidelines for the Diagnosis and Treatment of Cardiovascular Diseases (2007 Joint Working Groups Report) Guidelines for the Prevention and Treatment of Infective Endocarditis (JCS 2008). http://www.j-circ.or.jp/guideline/pdf/JCS2008_miyatake_h.pdf
Stuart G (2006) Maternal endocarditis. In: Steer PJ, Gatzoulis MA, Baker P (eds) Heart disease and pregnancy. RCOG Press, London, pp 267–282
Child JS, Pegues DA, Perloff JK (2009) Infective endocarditis and congenital heart disease. In: Perloff JK, Child JS, Aboulhosn J (eds) Congenital heart disease in adults, 3rd edn. Saunders/Elsevier, Philadelphia, pp 168–193
Siu SC, Sermer M, Colman JM et al (2001) Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 104:515–521
Khairy P, Ouyang DW, Fernandes SM et al (2006) Pregnancy outcomes in women with congenital heart disease. Circulation 113:517–524
Siu SC, Colman JM, Sorensen S et al (2002) Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 105:2179–2184
Briggs GG, Freeman RK, Yaffe SJ (eds) (2008) Drugs in pregnancy and lactation, 8th edn. Lippincott Williams & Wilkins, Philadelphia
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Niwa, K. (2019). Antepartum Management of Women with Cardiovascular Disease. In: Ikeda, T., Aoki-Kamiya, C. (eds) Maternal and Fetal Cardiovascular Disease. Springer, Singapore. https://doi.org/10.1007/978-981-10-1993-7_1
Download citation
DOI: https://doi.org/10.1007/978-981-10-1993-7_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-1991-3
Online ISBN: 978-981-10-1993-7
eBook Packages: MedicineMedicine (R0)